BRIEF-China Resources Sanjiu To Become Tasly's Controlling Shareholder

Reuters2024-08-04

Aug 4 (Reuters) - Tasly Pharmaceutical Group Co Ltd

* SAYS CONTROLLING SHAREHOLDER, PARTIES ACTING IN CONCERT AGREE TO SELL 28% STAKE IN THE COMPANY TO CHINA RESOURCES SANJIU MEDICAL

FOR 6.2 BILLION YUAN ($865.92 million)

* SAYS CONTROLLING SHAREHOLDER WILL CHANGE TO CHINA RESOURCES SANJIU, ACTUAL CONTROLLER WILL BE CHINA RESOURCES AFTER STAKE TRANSFER

* SAYS TRADING IN SHARES TO RESUME ON AUG 5

Source text 1

Source text 2

Further company coverage:

($1 = 7.1600 Chinese yuan renminbi)

(Reporting by Beijing newsroom)

((Ella.Cao@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2456782435?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-08-04 15:49","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2456782435","market":"hk","top_or_hot":-1,"title":"BRIEF-China Resources Sanjiu To Become Tasly's Controlling Shareholder","media":"Reuters","content":"<html><body><p>Aug 4 (Reuters) - Tasly Pharmaceutical Group Co Ltd</p><p> :</p><p>   * SAYS CONTROLLING SHAREHOLDER, PARTIES ACTING IN CONCERT AGREE TO SELL 28% STAKE IN THE COMPANY TO CHINA RESOURCES SANJIU MEDICAL</p><p>  FOR 6.2 BILLION YUAN  ($865.92 million)</p><p>   * SAYS CONTROLLING SHAREHOLDER WILL CHANGE TO CHINA RESOURCES SANJIU, ACTUAL CONTROLLER WILL BE CHINA RESOURCES AFTER STAKE TRANSFER</p><p>   * SAYS TRADING IN SHARES TO RESUME ON AUG 5</p><p>    Source text 1</p><p>   Source text 2</p><p>  Further company coverage:   </p><p>($1 = 7.1600 Chinese yuan renminbi)</p><p> (Reporting by Beijing newsroom)</p><p>((Ella.Cao@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-China Resources Sanjiu To Become Tasly's Controlling Shareholder</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-China Resources Sanjiu To Become Tasly's Controlling Shareholder\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-04 15:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Aug 4 (Reuters) - Tasly Pharmaceutical Group Co Ltd :   * SAYS CONTROLLING SHAREHOLDER, PARTIES ACTING IN CONCERT AGREE TO SELL 28% STAKE IN THE COMPANY TO CHINA RESOURCES SANJIU MEDICAL  FOR 6.2 ...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0012","symbol_name":"证金概念","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2456782435","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2456782435","pubTimestamp":1722757794,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Aug 4  - Tasly Pharmaceutical Group Co Ltd :   * SAYS CONTROLLING SHAREHOLDER, PARTIES ACTING IN CONCERT AGREE TO SELL 28% STAKE IN THE COMPANY TO CHINA RESOURCES SANJIU MEDICAL  FOR 6.2 BILLION YUAN     * SAYS CONTROLLING SHAREHOLDER WILL CHANGE TO CHINA RESOURCES SANJIU, ACTUAL CONTROLLER WILL BE CHINA RESOURCES AFTER STAKE TRANSFER   * SAYS TRADING IN SHARES TO RESUME ON AUG 5    Source text 1   Source text 2  Further company coverage:    ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK0012":"证金概念","BK0196":"行业龙头","BK0175":"白马股","000999":"华润三九","BK0010":"央企","BK0185":"二线龙头","BK0028":"国家队","BK0188":"融资融券","BK0060":"抗癌","BK0183":"MSCI概念","BK0239":"医药制造"},"translate_title":"简介-华润三九将成为天士力控股股东","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"000999":0.9},"content_text":"Aug 4 (Reuters) - Tasly Pharmaceutical Group Co Ltd :   * SAYS CONTROLLING SHAREHOLDER, PARTIES ACTING IN CONCERT AGREE TO SELL 28% STAKE IN THE COMPANY TO CHINA RESOURCES SANJIU MEDICAL  FOR 6.2 BILLION YUAN  ($865.92 million)   * SAYS CONTROLLING SHAREHOLDER WILL CHANGE TO CHINA RESOURCES SANJIU, ACTUAL CONTROLLER WILL BE CHINA RESOURCES AFTER STAKE TRANSFER   * SAYS TRADING IN SHARES TO RESUME ON AUG 5    Source text 1   Source text 2  Further company coverage:   ($1 = 7.1600 Chinese yuan renminbi) (Reporting by Beijing newsroom)((Ella.Cao@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.0","shortVersion":"4.30.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2456782435"}